Surveillance for hepatocellular carcinoma: in whom and how?
- PMID: 21317990
- PMCID: PMC3036965
- DOI: 10.1177/1756283X10385964
Surveillance for hepatocellular carcinoma: in whom and how?
Figures
References
-
- Arguedas M.R., Chen V.K., Eloubeidi M.A., Fallon M.B. (2003) Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost–utility analysis. Am J Gastroenterol 98: 679–690 - PubMed
-
- Bayati N., Silverman A.L., Gordon S.C. (1998) Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C. Am J Gastroenterol 93: 2452–2456 - PubMed
-
- Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35: 421–430 - PubMed
-
- Carr B.I., Kanke F., Wise M., Satomura S. (2007) Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States. Dig Dis Sci 52: 776–782 - PubMed
-
- Chen J.G., Parkin D.M., Chen Q.G., Lu J.H., Shen Q.J., Zhang B.C., et al. (2003) Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen 10: 204–209 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
